A B S T R A C T The mechanisms and kinetics of the immunosuppressive effects of alternate-day prednisone were investigated in a group of patients with a variety of inflammatory diseases receiving a range of alternateday prednisone doses from 5 to 120 mg. Total circulating lymphocyte and monocyte counts, as well as proportions of lymphocyte subpopulations defined both by surface markers and by in vitro functional capacities, were studied. At 8 a.m. of the day on prednisone, just before drug administration, lymphocyte and monocyte counts, proportions of lymphocyte subpopulations, as well as in vitro lymphocyte blastogenic responses to various mitogenic and antigenic stimuli were normal. 4 h after the administration of prednisone, there was a profound lymphocytopenia and monocytopenia, with a differential depletion of thymus-derived lymphocytes as well as various functionally defined lymphocyte subpopulations. Lymphocyte kinetic studies using radioactive chromiumlabeled autologous lymphocytes showed that the lymphocytopenia was due predominantly to a transient depletion of the recirculating portion of the intravascular lymphocyte pool. All these parameters returned to normal by 8 a.m. of the following day (off prednisone) and remained normal throughout the day. This very transient lymphocytopenia and monocytopenia after prednisone, with normal cell numbers, proportions, and functions throughout the remainder of the 2-day cycle, was associated with suppression of disease activity, yet did not affect cutaneous delayed hypersensitivity in these patients nor increase the likelihood of infectious complications. This drug-associated cyclic and transient monocytopenia and selective lymphocytopenia is best explained by a redistribution of recirculating lymphocytes
A B S T R A C T The mechanisms and kinetics of the immunosuppressive effects of alternate-day prednisone were investigated in a group of patients with a variety of inflammatory diseases receiving a range of alternateday prednisone doses from 5 to 120 mg. Total circulating lymphocyte and monocyte counts, as well as proportions of lymphocyte subpopulations defined both by surface markers and by in vitro functional capacities, were studied. At 8 a.m. of the day on prednisone, just before drug administration, lymphocyte and monocyte counts, proportions of lymphocyte subpopulations, as well as in vitro lymphocyte blastogenic responses to various mitogenic and antigenic stimuli were normal. 4 h after the administration of prednisone, there was a profound lymphocytopenia and monocytopenia, with a differential depletion of thymus-derived lymphocytes as well as various functionally defined lymphocyte subpopulations. Lymphocyte kinetic studies using radioactive chromiumlabeled autologous lymphocytes showed that the lymphocytopenia was due predominantly to a transient depletion of the recirculating portion of the intravascular lymphocyte pool. All these parameters returned to normal by 8 a.m. of the following day (off prednisone) and remained normal throughout the day. This very transient lymphocytopenia and monocytopenia after prednisone, with normal cell numbers, proportions, and functions throughout the remainder of the 2-day cycle, was associated with suppression of disease activity, yet did not affect cutaneous delayed hypersensitivity in these patients nor increase the likelihood of infectious complications. This drug-associated cyclic and transient monocytopenia and selective lymphocytopenia is best explained by a redistribution of recirculating lymphocytes INTRODUCTION Alternate-day corticosteroid therapy has become a widely employed and highly effective mode of therapy in a variety of conditions, including childhood nephrotic syndrome (1), chronic asthma (2) , renal transplantation (3, 4) , as well as various inflammatory or autoimmune diseases (5) (6) (7) (8) . It is a particularly attractive mode of therapy since the serious cushingoid side effects associated with daily prednisone therapy have been shown to be absent or markedly diminished (9, 10) . In addition, cutaneous delayed hypersensitivity remains intact (10) , and the increased incidence of infectious complications frequently encountered with long-term, daily prednisone therapy is not found with alternate-day regimens (10, 11) .
The diseases in question are thought to be mediated by inflammatory and/or immunological mechanisms. It is assumed but not proved that suppression of disease activity by alternate-day corticosteroid therapy results from the suppression of various measurable parameters of the immune response. If the suppression of the immune response is indeed correlated with the suppression of disease activity, it is unclear how such immunosuppression occurs, in light of intact cutaneous delayed hypersensitivity and apparent lack of increased susceptibility to infection in patients on alternate-day corticosteroid therapy. The present study is aimed at elucidating the extent and the kinetics of the measurable immunosuppression associated with alternate-day prednisone therapy to understand better this dichotomy between clinical immunosuppression and apparently intact host defenses.
Recently, we have demonstrated that a single intravenous dose of hydrocortisone in normal human beings causes a profound and transient lymphocytopenia and
The Journal of Clinical Investigation Volume 55 January 1975 22-32 22 These two patients had lymphocyte transformation studies done as well as 5'Cr-labeled lymphocyte kinetic studies. They were receiving the above doses of prednisone during the lymphocyte transformation studies. Both were receiving 60 mg on alternate days during the labeling studies.
§ Only the effect of prednisone on the kinetics of 5'Cr-labeled lymphocytes was studied in these two patients.
monocytopenia, maximal at 4-6 h after injection, with a return to normal by 24 h (12). In addition to the absolute lymphocytopenia, we also noted a differential depletion of lymphocyte subpopulations as measured by a proportionately greater decrease in thymus-derived (T)1 lymphocytes, and a selective depletion of lymphocyte subpopulations functionally defined by in vitro responses to various mitogens and antigens. A selective depletion of circulating T lymphocytes has also been shown to result from single doses of orally administered prednisone (13) .
'Abbreviations used in this paper: B, bone marrow-derived; ConA, concanavalin A; HBSS, Hanks' balanced salt solution; MEM-S, Eagle's minimum essential medium modified for suspension culture; PHA, phytohemagglutinin; PWM, pokeweed mitogen; RBC, erythrocytes; SK-SD, streptokinase-streptodornase; SRBC, sheep erythrocytes; T, t'iymus-derived; TCA, trichloroacetic acid; TT, tetanus toxcid; WBC, leukocytes.
To investigate the mechanisms and kinetics of the immunosuppressive effects of single-dose alternate-day corticosteroid therapy, patients on various doses of alternate-day prednisone were studied at different times during their day on and off the drug, and the following parameters were measured: absolute numbers of circulating lymphocytes and monocytes, relative proportions and absolute numbers of circulating T lymphocytes, and the function of lymphocyte subpopulations as determined by in vitro blastogenic responses to stimulation with various mitogens and antigens. In addition, the effects of alternate-day prednisone administration on the kinetics of radioactive chromium-labeled lymphocytes were also studied. METHODS Subjects. 17 patients, 9 men, 8 women, ranging in age from 17 to 66 yr, with a variety of nonneoplastic diseases, were studied while on alternate-day prednisone therapy. The diagnoses, prednisone doses, and duration of therapy at the time of study are listed in Table I . Three patients (J. T., NV. H., and E. K) are given the diagnosis of fever of unknown origin. They have been closely followed for 31-11i yr at the National Institute of Allergy and Infectious Diseases for frequent, intermittent, febrile illnesses without a specific diagnosis. Extensive and repeated workups over the years have failed to reveal the causes of their fevers. Their fevers have been successfully suppressed with alternate-day prednisone. Attempts to taper and discontinue the drug in these patients have resulted in return of fever.
For purposes of the lymphocyte studies, the patients have been divided into three groups: those receiving a low dose (5-20 mg) of prednisone, those receiving a medium dose (2540 mg), and those receiving a high dose (60-120 mg) on alternate days. In the subsequent figures and tables in which the data are reported for patients in these prednisone dosage groups, every lymphocyte study was done on each individual patient listed in the particular dosage groups in Table I 20 IAI of 1:10 dilution in distilled water/0.2 ml of culture. The antigens used were: SK-SD, optimal dose 24 U streptokinase, 6.75 U streptodornase/ml of culture; tetanus toxoid (TT), lot L 0.246 (Eli Lilly and Co.), optimal dose 1.5 flocculation U/ml of culture. Cultures containing mitogens were incubated for 3 days and those containing antigens were incubated for 5 days. In addition, in several experiments, mitogen cultures were incubated for 4 and 5 days as well, to control for any changes in the kinetics of the cultures caused by prednisone administration. 4 h before harvesting, 0.4 ,uCi of tritiated thymidine (6.7 Ci/mM, New England Nuclear, Boston, Mass.) was added to each well. The cells were collected from the wells onto fiberglass filters by a semiautomated micro-harvesting device (15) . The filters were washed with 10% trichloroacetic acid (TCA) and 95% ethanol, and placed in 10 ml of Aquasol (New England Nuclear). The TCA-precipitable radioactivity was counted in a liquid scintillation counter (Model LS-350, Beckman Instruments, Inc., Fullerton, Calif.). The arithmetic mean of the counts per minute of quadruplicate cultures was determined and the degree of stimulation expressed as the difference in counts per minute per 10' lymphocytes between stimulated and unstimulated (control) cultures (A cpm).
Proportion of circulating T lymphocytes. The percentage of circulating lymphocytes that formed rosettes with sheep red blood cells (SRBC) was determined (16) . In this assay T lymphocytes, but not bone marrow-derived (B) lymphocytes, bind SRBC to form rosettes. To 0.25 ml ot the lymphocyte suspension (4 X 106 cells/ml) in Hank's balanced salt solution (HBSS) (National Institutes of Health Media Supply Section) was added 0.25 ml of 0.5% SRBC, which had been neuraminidase treated (17) . The mixed cell suspension was incubated at 370C for 5 min and centrifuged at 200 g for 5 min at 40C, and the supernatant HBSS was removed. 0.5 ml of fetal calf serum (Gray Industries, Inc., Fort Lauderdale, Fla.), absorbed twice with SRBC, was added and the pellet incubated at 40C overnight. One-half the volume of supernate was then removed and the cells were gently resuspended by shaking. One drop of cell suspension was put on a glass slide and a cover slip applied. 200 lymphocytes were counted by the same observer throughout the study with phase contrast optics at 400 X magnification on a Zeiss microscope (Carl Zeiss, Inc., New York). The observer did not know which patient was being studied nor whether it was the day on or off prednisone. All lymphocytes binding more than three SRBC were considered positive. The Total lymphocyte-associated radioactivity as well as the specific activity of lymphocytes (cpm/10@ lymphocytes) were determined from an 8-ml aliquot of labeled cells taken from the bag before reinfusion, and from 20-ml samples of blood drawn at 15 min, 1, 3, 6, 12 , and 24 h after the reinfusion. In the patient studies, prednisone was administered after the 24 h blood sample, and further samples were obtained at 4, 8, 12, 24, 28 , and 48 h after prednisone. Another prednisone dose was given 48 h after the previous dose and the same blood-drawing protocol as above was repeated, i.e., with samples obtained at 4, 8, 12, 24 , and 28 h after drug administration. Normal control subjects were studied in the same manner except that they did not receive prednisone.
The lymphocytes were separated from each sample by the Hypaque-Ficoll method (14) . The Hypaque-Ficollseparated mononuclear cells will hereafter be referred to as "lymphocytes" with the awareness that these cells are approximately 85% lymphocytes, 15% monocytes, and less than 1% granulocytes. During the study, several Hypaque-Ficollseparated cell samples drawn 24 h or more after the reinfusion of labeled cells were also plated on glass Petri dishes to remove monocytes by adherence, and it was found that, indeed, more than 95% of the radioactivity was associated with the lymphocytes. This was probably due to the fact that most of the reinfused labeled monocytes had left the circulation by this time. Hence, we will refer to the activity of these Hypaque-Ficoll-separated mononuclear cells as "lymphocyte-associated radioactivity." The yield of lymphocytes in the Hypaque-Ficoll preparations was approximately 85% of the lymphocytes in the whole blood samples. This was consistent and reproducible, and there was no difference in the percentage of lymphocyte yield in Hypaque-Ficoll preparations compared to whole blood in the samples drawn either before or after prednisone administration. Cells were counted in a Coulter Counter, and radioactivity was measured in an automatic gamma counter (Series 1185, Nuclear-Chicago Corp., Des Plaines, Ill.). The total lymphocyte-associated radioactivity remaining in the circulation at each time point was calculated by converting the lymphocyte-associated radioactivity in the 20-ml sample to the amount in the total intravascular blood compartment, assuming blood volume as 7% of body weight (19) .
Body surface counts were measured at each time point over the spleen, sternal bone marrow, and liver, with a Tri-Carb scintillation spectrometer with a shielded 2-in thallium-activated sodium iodide crystal (Model 3002, Packard Instrument Co., Inc., Downers Grove, IlL) (20) .
As described above, we chose to label and reinfuse dextran-sedimented WBC rather than separated lymphocytes for several reasons. First, it allows for minimal manipulation of cells before reinfusion, thus lessening the chance of damaging or altering cells. Second, Hypaque-Ficoll separation of lymphocytes before reinfusion, with subsequent labeling of just lymphocytes, would require removing cells from the sterile, sealed bags, allowing a slight but definite chance of contamination that we felt obligated to avoid in these studies. Third, removal of granulocytes and monocytes by passage of cells over nylon or glass bead columns before labeling was undesirable, since this procedure is known to remove selectively certain lymphocyte populations (21, 22) . RESULTS Cutaneous delayed hypersensitivity. Fig. 1 . There was no significant difference (Student's t test) between the mean total lymphocyte count at 8 a.m. of normal controls and the mean total lymphocyte count at 8 a.m. of either the on day (P > 0.2 for all three prednisone dose groups) or the off day (P > 0.2 for the low and mediumdose groups; P > 0.05 for the high-dose group) of patients receiving alternate-day prednisone. However, 4 h after prednisone there was a significant decrease in circulating lymphocyte counts of patients in all dose groups (low dose, P < 0.02, medium dose, P < 0.05, high dose, P < 0.05). The lymphocyte counts in all three dose groups returned to normal by 8 a.m. of the off day and remained so through 8 a.m. of the following on day.
The effect of alternate-day prednisone on the total numbers of circulating monocytes is depicted in Fig. 2 .
The 10 normal controls receiving no drug had a mean± SEM monocyte count of 305±-37/mm' at 8 a.m. and 359+35/mm' at 12 noon. There was no significant difference (P > 0.2) between the mean total monocyte count at 8 a.m. of normal controls and the mean total monocyte count at 8 a.m. of either the on day or the off day of patients receiving alternate-day prednisone in the low and high-dosage groups. The mean monocyte count of the medium-dose group was slightly higher (P < 0.05) than that of normal controls. 4 h after prednisone, there was a slight but not significant decrease in mean monocyte count in the low-dose prednisone group, while in the medium and high dose groups there were significant decreases in mean monocyte counts (P < 0.05) at 12 noon, which returned to normal by 8 a.m. of the off day and remained normal through 8 a.m. of the following on day.
Circulating T lymphocytes. Table III shows the effect of alternate-day prednisone therapy on both the proportion and total numbers of circulating T lymphocytes. At 8 a.m. of the on day, both the proportion and total numbers of circulating T lymphocytes in all three dose groups were no different from normal controls. 4 h after prednisone there was a significant decrease in both the proportion and total numbers of circulating T lymphocytes in all three groups, indicating not only an absolute T lymphocytopenia, but also a selectively greater depletion of the T lymphocyte population as compared to the decrease in total lymphocyte count. Both the proportion and total numbers of T lymphocytes returned to nor- Lymphocyte blastogenic responses. Table IV shows the effect of alternate-day prednisone therapy on lymphocyte blastogenic responses to various mitogens and antigens. The data given are for optimal stimulatory doses of mitogens and antigens. In several subjects in whom a range of stimulatory doses was examined, there were no essential differences in the patterns of suppression. In addition, mitogen cultures harvested at 4 and 5 days likewise showed no differences in the patterns of suppression. At 8 a.m. of the on day of prednisone, there was no significant difference between normal controls and any of the three patient groups in the lymphocyte blastogenic responses to the mitogens PHA, ConA, PWM, and the antigen SK-SD. All three patient groups had significantly lower mean lymphocyte blastogenic responses to TT than normal controls (low dose group, P <0.02; medium dose group, P <0.05; high dose group, P < 0.05). 4 h after prednisone, at the point of maximal lymphocytopenia, there was a differential decrease in lymphocyte blastogenic responses to various mitogens and antigens of the lymphocytes that had remained in the circulation. To obtain a more reliable determination of the actual drug-induced changes in response to the various mitogens and antigens 4 h after prednisone, the following analysis was performed: the ratio of the blastogenic responses at 8 a.m. and 12 noon of the on day was compared with the ratio of the responses at 8 a.m. and 12 noon of the off day for each individual patient. In this way, the off day data served as an internal control for normal variability in lymphocyte blastogenic responses between 8 a.m. and 12 noon for each patient. Hence, the ratio (r) of (cpm at 12 noon of on day/cpm at 8 a.m. of on day)/(cpm at 12 noon of off day/cpm at 8 a.m. of off day) was calculated for each patient. The mean r±SEM was obtained for each stimulus in each dosage group. Thus, mean per cent change in stimulation = 100% -mean r. To determine the statistical significance of these changes, a Student's t test was performed where t = mean % change/ (+SEM) (23) . (18) . By 1 h after infusion, the percent of total injected lymphocyte-associated radioactivity remaining in the circulation was less than 50% for patients and controls. To evaluate more appropriately the effect of prednisone on the labeled cells in a steady state after equilibrium with the extravascular lymphocyte compartments had been reached, the amount of lymphocyte-associated radioactivity left in the circulation at any given time, as well as the specific activity of lymphocytes, was expressed as the percent of the 1-h value (19) . Fig. 3 illustrates the effect of alternate-day prednisone on the circulating labeled lymphocytes. The upper panel shows that over the 4 days of study, the lymphocyte counts of the untreated normal controls remained relatively constant. In contrast, the patients had a sharp decrease in circulating lymphocyte counts 4 h after each prednisone dose with return to normal counts by 24 h. This is in accord with the findings in the other patients on alternate-day prednisone (Fig. 1) . The lower panel of Fig. 3 illustrates that there was no difference between the patients and controls in the lymphocyte-associated radioactivity remaining in the circulation throughout the study. Hence, prednisone administration did not af-
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A. S. Fauci and D. C. Dale fect the labeled lymphocytes in the circulation at the time of drug administration. The middle panel of Fig. 3 shows that the lymphocyte specific activity of the control subjects followed a linear decay curve, while that of the patients showed a marked increase precisely concomitant with the prednisone-induced lymphocytopenia, with a return of the specific activity to values similar to the decay curve of the controls as the lymphocyte counts returned to normal. This exact phenomenon was seen during the following cycle of alternate-day prednisone dosage. Hence, the lymphocytopenia caused by prednisone was of the nonlabeled lymphocytes, since the amount of lymphocyte-associated radioactivity was unchanged, while the specific activity increased during the decrease in lymphocyte counts. Surface body counting over various organs (spleen, sternal bone marrow, and liver) indicated that after the initial equilibration of labeled lymphocytes between the intravascular and extravascular lymphocyte compartments, there was a gradual linear decrease in counts over each organ (Fig. 4) , similar to that reported elsewhere (19) . There was no apparent difference in the distribution of labeled lymphocytes between the organs counted in the controls and patients, and there was no appreciable change in the pattern of surface counting after administration of prednisone. Hence, unlabeled and not labeled lymphocytes were depleted by prednisone administration. Likewise, there was no redistribution of labeled lymphocytes already present in the various organs at the time of prednisone administration that could be detected by surface body counting.
DISCUSSION
The precise relationships between alternate-day prednisone therapy, clinical immunosuppression, and the suppression of disease activity are uncertain. In the present study several points concerning the circulating lymphocytes and monocytes of patients on alternateday prednisone therapy are clear. At 8 a.m. of the on day, immediately before administration of prednisone, Mean percent change (%SEM). the total circulating lymphocyte and monocyte counts of patients in all three dosage groups were normal. After prednisone administration, there was a profound but transient lymphocytopenia and monocytopenia, which was maximal at 4 h. By 8 a.m. of the off day, the counts returned to normal and remained normal throughout the off day, through 8 a.m. of the following on day when the next cycle of alternate-day dosage began. Hence, in these patients on alternate-day prednisone therapy, chronic treatment, even as long as several years did not result in a cumulative lymphocytopenia and monocytopenia. There continued to be cyclic transient decreases in circulating counts after therapy, with counts decreased for only a few hours every 2 days. This same type of transient lymphocytopenia and monocytopenia was noted after intravenous administration of a single dose of hydrocortisone to normal volunteers (12) (12) .
HOURS
The fate of these depleted lymphocytes during this pe-TIME AFTER INJECTION OF LABELED LYMPHOCYTES riod of corticosteroid-induced lymphocytopenia is unsE 4 Effect of alternate-day prednisone administra-certain. It is highly unlikely that these cells are de-)fn the organ distribution of reinfused 5Cr-labeled stroyed, both because of the rapid return to normal of gous lymphocytes detectable by surface body counting. the levels of circulating cells and because it has been .d cells are reinfused at time 0 on the horizontal Data on the vertical scale for the organ activity are clearly shown that in vitro incubation of human lymphoas the percent of the 1-h value for each subsequent cytes with suprapharmacological levels of corticosteroids )oint. The means (±-SEM) for the four normal con-does not cause cell lysis or affect viability (27, 28) . It nd four patients are given.
has been suggested that lymphocytes are redistributed out of the circulation into other body compartments Lr effects have been reported after oral prednisone (12, 13) . This theory is based on convincing evidence lunteers (13) . A similar decrease in circulating in mice that corticosteroid treatment results in a reLocytes has been noted 6 h after prednisone in a distribution and accumulation of T lymphocytes in the of children with chronic asthma on alternate-day bone marrow (29) (30) (31) . However, the mouse is a ,isone therapy (24 of lymphocytes in the bone marrow (33) . This evidenc is suggestive that a redistribution of circulating lympho cytes into the bone marrow after prednisone may explaii the current findings. Labeling studies in the rat havy shown that corticosteroids cause a homing of T lympho cytes to the bone marrow (34) . This was done by re infusing 'Cr-labeled thoracic duct or thymic lympho cytes and examining whole organs for labeled cells dur ing corticosteroid treatment.
The extent to which lymphocyte labeling studies in human beings can provide information about the localization of reinfused peripheral blood lymphocytes after corticosteroid administration is somewhat limited. There are several reasons for this limitation. Peripheral blood lymphocytes consist of two populations of cells. One is a short-lived nonrecirculating population of cells that do not migrate from the circulation and the other is a long-lived recirculating population of cells that freely move into and out of the circulation in equilibrium with the vastly larger extravascular portion of this rccirculating pool contained in the thoracic duct lymph, spleen, lymph nodes, and bone marrow (35, 36) . When lymphocytes are labeled and reinfused, the labeled recirculating cells become markedly diluted out during the rapid equilibration with the intravascular and extravascular recirculating pools. Precise quantitation by surface body counts of changes in organ distribution is difficult and at best only a gross estimation of true radioactivity in these organs (18) . The numbers of lymphocytes that must be labeled as well as the intensity of labeling required to detect changes in distribution within this enormous pool of cells by this method would be unacceptable in human experimentation. However, these labeling studies have provided important information concerning the relative effects of alternate-day prednisone administration on these different lymphocyte pools within the circulation. After the reinfusion of labeled lymphocytes in the normal control subjects, there was an initial rapid equilibration of labeled lymphocytes with the intravascular and extravascular pool, followed by a gradual linear decrease in amount of labeled lymphocytes and specific activity of lymphocytes over the 4-day study period (Fig. 3) . The lymphocyte counts remained constant. It is reasonable to assume that the infused labeled recirculating lymphocytes, capable of migrating into and out of the circulation via certain distinct channels (37, 38) , have been diluted into the vastly larger total body recirculating pool, and so the labeled lymphocytes remaining in the circulation belong predominantly to the nonrecirculating pool of lymphocytes, which are incapable of migrating out of the circulation (35) . Due to the equilibration and dilution mentioned above, the labeled recirculating lymphocytes reinfused have been largely replaced in the circulation by e unlabeled recirculating lymphocytes from the extravascular pool. This theory is strongly supported by the data nin Fig. 3 . After prednisone administration, despite the e profound lymphocytopenia, there is no change in the amount of lymphocyte-associated radioactivity in the circulation, while the lymphocyte specific activity markedly increases. This clearly demonstrates that the prednisone has no effect on the numbers of labeled cells, presumably nonrecirculating lymphocytes, in the cirIculation at that time.
We can conclude from these data that these nonrecirrculating labeled lymphocytes in the circulation are truly a distinct population from the unlabeled recircuIlating cells that have been depleted by prednisone. If this were not true, and these nonrecirculating labeled cells were depleted by prednisone, then the total lymphocyte-associated radioactivity would have decreased, which is clearly not the case (Fig. 3) . The prednisone-induced lymphocytopenia appears to be entirely within the unlabeled recirculating pool. The fact that the lymphocyte specific-activity returns to the normal linear decay slope when the lymphocyte counts return to normal (Fig. 3) indicates that unlabeled recirculating lymphocytes from the extravascular pool must be replacing the unlabeled recirculating lymphocytes depleted by prednisone. Hence, these labeling studies, though not sufficiently sensitive to indicate precisely where lymphocytes are redistributed after prednisone administration, do demonstrate that the lymphopenic effects of the drug are predominantly on the recirculating lymphocytes capable of normally migrating into and out of the circulation in equilibrium with the much larger extravascular portion of the recirculating pool. Prednisone administration does not deplete the nonrecirculating lymphocytes that are not capable of normally migrating out of the circulation.
13 of our 15 patients had intact cutaneous delayed hypersensitivity and none have had problems with infectious complications of corticosteroid therapy. Thus, these alternate-day prednisone regimens, transiently suppressing specific lymphocyte subpopulations on alternate days, are not appreciably affecting critical host defense mechanisms. However, in several patients in whom tapering of steroid dosage was attempted, flareup of disease activity occurred. Hence, the drug is clearly responsible for suppression of disease activity.
The precise relationship between the transient depletion of these lymphocyte populations and the suppression of disease activity is unclear at present. Should we begin to find direct associations between lymphocyte subpopulations and various immunologically mediated diseases, this selective suppression will assume more clinical relevance.
